T-Cell Engager-Armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy

被引：0
|
作者：
Yu, Feng [1 ]
Gottschalk, Stephen M. [1 ]
Song, Xiao-Tong [1 ]
机构：
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2013年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
410
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy
    Yu, Feng
    Wang, Xingbing
    Guo, Z. Sheng
    Bartlett, David L.
    Gottschalk, Stephen M.
    Song, Xiao-Tong
    MOLECULAR THERAPY, 2014, 22 (01) : 102 - 111
  • [2] Bi-specific T-cell engager-armed oncolytic adenoviruses as a strategy to improve antitumor efficacy
    Alberto Fajardo, Carlos
    Moreno, Rafael
    Alfonso Rojas, Luis
    Arias, Marcel
    Alemany, Ramon
    HUMAN GENE THERAPY, 2015, 26 (09) : A13 - A14
  • [3] Targeting the tumor stroma with a bispecific T-cell engager-armed oncolytic adenovirus
    de Sostoa Pomes, J.
    Fajardo, C. A.
    Moreno, R.
    Ramon, M. D.
    Farrera Sal, M.
    Alemany, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 34 - 34
  • [4] Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses
    Scott, Eleanor M.
    Duffy, Margaret R.
    Freedman, Joshua D.
    Fisher, Kerry D.
    Seymour, Leonard W.
    MACROMOLECULAR BIOSCIENCE, 2018, 18 (01)
  • [5] Arming oncolytic vaccinia virus with T cell engager to improve virus therapy
    Song, Xiaotong
    Yu, Feng
    Gottschalk, Stephen
    Bartlett, David
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [6] Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer
    Liu, Shiyu
    Li, Fan
    Deng, Li
    Ma, Qiongqiong
    Lu, Wenyi
    Zhao, Zhuoqian
    Liu, Huanzhen
    Zhou, Yixuan
    Hu, Manli
    Wang, Hui
    Yan, Yingbin
    Zhao, Mingfeng
    Zhang, Hongkai
    Du, Mingjuan
    MOLECULAR THERAPY ONCOLYTICS, 2023, 30 : 275 - 285
  • [7] Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors
    Wei, Min
    Zuo, Shuguang
    Chen, Zhimin
    Qian, Peng
    Zhang, Yenan
    Kong, Lingkai
    Gao, Honglan
    Wei, Jiwu
    Dong, Jie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy
    Guo, Zong Sheng
    Lotze, Michael T.
    Zhu, Zhi
    Storkus, Walter J.
    Song, Xiao-Tong
    BIOMEDICINES, 2020, 8 (07)
  • [9] Bispecific T cell engager-armed T cells targeting integrin αvβ6 exhibit enhanced T cell redirection and antitumor activity in cholangiocarcinoma
    Suwanchiwasiri, Kwanpirom
    Phanthaphol, Nattaporn
    Somboonpatarakun, Chalermchai
    Yuti, Pornpimon
    Sujjitjoon, Jatuporn
    Luangwattananun, Piriya
    Maher, John
    Yenchitsomanus, Pa-thai
    Junking, Mutita
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [10] Improving CAR-T Cell Therapy with Oncolytic Virus-Driven Production of Bispecific T-Cell Engager
    Wing, Anna K.
    Guedan, Sonia
    Fajardo, Carlos A.
    Shaw, Carolyn
    Da, Tong
    Alemany, Ramon
    June, Carl H.
    MOLECULAR THERAPY, 2017, 25 (05) : 362 - 362
12345